Our Research Advisory Group (RAG) is comprised of experts in childhood cancer with varied specialisms. Members come from various centres across the UK to ensure that the committee is balanced and that decisions are well informed and impartial.
Our RAG is independent of our Board of Trustees.
What does the RAG do?
Using their differing perspectives and areas of expertise, they apply their own expertise in addition to the peer reviews of applications to ensure high quality research recommendations are made to our Board of Trustees/Executive (for research funded directly by CCLG) or to the Board of Trustees of our partner charities (where CCLG is managing a research funding programme on behalf of another charity).
Our RAG members are all volunteers who give us their time and expertise for free. We are extremely grateful to them.
Find out more about how our CCLG funds research and how our RAG supports this
Professor Andrew Peet – Chair
NIHR Research Professor in Paediatric Neuro-Oncology, University of Birmingham
Research Director, NIHR 3T MRI Research Centre and Consultant Paediatric Oncologist, Birmingham Children’s Hospital
Professor Peet’s research focusses on the development and evaluation of novel MRI techniques for diagnosis, management and understanding childhood cancer and neurological diseases. The imaging research is underpinned by a laboratory programme which focusses on tumour metabolism. He has more than 100 publications in the field.
Professor Peet has led national and international collaborations aiming to ensure that the techniques his team develops benefit as many patients as possible. He currently co-chairs the International Society of Pediatric Oncology Europe (SIOPE) Brain Imaging group, is the vice chair of the International Society of Magnetic Resonance in Medicine (ISMRM) Pediatric Study Group and is the chair of the Children’s Cancer and Leukaemia Group’s Research Advisory Group.
Professor Richard Grundy
Researcher in paediatric neuro-oncology and cancer biology, Children's Brain Tumour Research Centre in Nottingham
Consultant Paediatric Oncologist, Nottingham University Hospitals NHS Trust
Richard is a world-renowned researcher in brain tumours at the University of Nottingham where he also treats children with brain tumours as an Honorary Consultant Paediatric Oncologist at the Queen's Medical Centre in Nottingham.
Dr Richard Feltbower
Senior Lecturer in Epidemiology, University of Leeds
Richard’s research interests focus on the epidemiology of cancer in children, teenagers and young adults where he leads the research programme for the Yorkshire Register of Cancer in Children and Young People. Other research interests include the impact of specialist care for Teenagers and Young Adults on survival and long-term health; late effects emerging following cancer treatment for childhood and young adult survivors; exploitation of Hospital Episode Statistics (HES) data to monitor hospital activity; delays in diagnosis for children and young adults with cancer and impact on long-term health; delivery of care among young people with cancer and impact on clinical outcomes.
Lead on Childhood Cancer for National Cancer Intelligence Network, Public Health England
Lecturer in Statistics, New College, University of Oxford
Charles is a long-standing member of the Children's Cancer and Leukaemia Group and of Teenagers and Young Adults with Cancer. He is Lead on Childhood Cancer with the National Cancer Intelligence Network, Public Health England, and was previously for many years Senior Research Fellow and Director of the National Registry of Childhood Tumours in the Childhood Cancer Research Group at the University of Oxford. He has published widely on the epidemiology of childhood cancer and is a collaborator on international studies using cancer registry data, including CONCORD-2 (worldwide population-based study of cancer survival), EUROCARE (population-based cancer survival in Europe), International Incidence of Childhood Cancer and the Automated Childhood Cancer Information System. Charles is also a member of the Scientific Advisory Committee of the Childhood Eye Cancer Trust and of the Scientific Advisory Panel of Children with Cancer UK.
Dr Christina Halsey
Senior Clinical Lecturer, University of Glasgow
Honorary Consultant Paediatric Haematologist, Royal Hospital for Children, Glasgow
Christina carries out her NHS clinical duties at the Royal Hospital for Children, Glasgow, where she cares for children with a wide range of malignant and non-malignant blood disorders. Her research lab is based in the Institute of Cancer Sciences, University of Glasgow where she investigates mechanisms of central nervous system disease in childhood acute lymphoblastic leukaemia (ALL) and ways to reduce treatment related toxicity in this condition. Dr Halsey is one of the organisers of Childhood leukaemia Research UK meetings, is an active member of the International BFM (iBFM) Childhood Leukaemia Study Group and is Chair of the Methotrexate Stroke Like Syndrome and seizures working parties in the Ponte di Legno/iBFM Toxicity Working Group.
Professor Faith Gibson
Professor of Cancer and Child Health, Great Ormond Street Hospital for Children NHS Foundation Trust and University of Surrey
Faith Gibson has over 25 years experience in children’s cancer nursing: that includes periods in clinical practice, education and research. She took up her current post, which is a joint appointment, in April 2016. Her main fields of research and supervision include:
- Improving process and outcomes of care for children/young people with cancer and their families.
- Improving assessment and management of symptoms.
- Improving skills of the nursing workforce to deliver cancer care.
- Improving survivorship care.
Professor Mehmet Dorak
Professor in Health Sciences, Liverpool Hope University
Profesdor Dorak originally trained in medicine followed by a BA, and PhD in genetics. Since 1991, he has been involved in biomedical research mainly in genetic epidemiology. His work has identified risk markers for childhood leukaemia in the HLA complex, in other immunoregulatory regions and in the HFE gene which is involved in iron homeostasis. He has published more than 70 peer-reviewed articles in journals like Blood, Lancet, Nature Medicine, and Genes & Immunity, and presented more than 160 conference papers. His current work makes use of the big data generated by recently completed human genomics projects, and focuses on the HLA region variants. This work uses bioinformatics approaches to identify cancer susceptibility markers and especially their gender-specificity. The aim is to characterise the mechanisms of cancer associations observed with HLA-linked variants.
Dr Jessica Bate
Consultant Paediatric Oncologist, University Hospital Southampton
National Ewing Sarcoma Multi-discplinary Team (NEMDT) Fellow, University College London
Jessica graduated from Cambridge University and the Royal Free University College London Medical School in 2001. She completed her clinical training in paediatric oncology at Great Ormond Street and the Royal Marsden. During her training, she was appointed as a Clinical Lecturer at St George’s, University of London (2008-2011).
Dr Bate has extensive clinical research experience within paediatric oncology and is an NIHR grant holder. She has a strong interest in sarcoma, supportive care and patient / public involvement in research. She has recently been appointed as the National Ewing Sarcoma Multi-disciplinary Team (NEMDT) Fellow, hosted at University College London and supported by the Bone Cancer Research Trust.
Dr Gita Mistry
CCLG Tissue Bank Manager
Dr Amy Mitchell
Paediatric Oncology GRID Trainee